Prevalence of Glaucoma Among US Adults in 2022.


Journal

JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539

Informations de publication

Date de publication:
17 Oct 2024
Historique:
medline: 17 10 2024
pubmed: 17 10 2024
entrez: 17 10 2024
Statut: aheadofprint

Résumé

Glaucoma is the leading cause of irreversible blindness worldwide and, in the US, disproportionately affects people from racial and ethnic minority groups. Glaucoma prevalence has not been estimated for the US in more than a decade, and state- and county-level estimates are not available. To estimate glaucoma and vision-affecting glaucoma prevalence by demographic factors and US state and county for the Centers for Disease Control and Prevention's Vision and Eye Health Surveillance System (VEHSS). This meta-analysis used data from the National Health and Nutrition Examination Survey (2005-2008), Medicare fee-for-service claims (2019), IBM MarketScan commercial insurance claims (2016), population-based studies of eye disease (1985-2003), and 2022 population estimates from the US Census Bureau. PubMed was searched for population-based studies of glaucoma prevalence published between 1991 and 2016. Bayesian meta-regression methods were used to estimate the prevalence of glaucoma and vision-affecting glaucoma stratified by age, undifferentiated sex/gender (a measure that captures an unclear mix of aspects of sex and or gender), race and ethnicity, and US county and state. Prevalence of any type of glaucoma (open or closed angle) among people 18 years or older and vision-affecting glaucoma, defined as glaucoma and a visual field abnormality. For 2022, an estimated 4.22 million people (95% uncertainty interval [UI], 3.46 million to 5.23 million) in the US were living with glaucoma, with a prevalence of 1.62% (UI, 1.33%-2.00%) among people 18 years or older and 2.56% (UI, 2.10%-3.16%) among people 40 years or older. An estimated 1.49 million people (UI, 1.17 million to 1.90 million) were living with vision-affecting glaucoma, with a prevalence of 0.57% (UI, 0.45%-0.73%) among people 18 years or older and 0.91% (UI, 0.71%-1.16%) among people 40 years or older. Prevalence of glaucoma among people 18 years or older ranged from 1.11% (UI, 0.89%-1.40%) in Utah to 1.95% (UI, 1.57%-2.39%) in Mississippi. Black adults had a prevalence of 3.15% (UI, 2.32%-4.09%) compared with 1.42% (UI, 1.10%-1.85%) among White adults; adults in the Hispanic and all other racial and ethnic categories combined had a prevalence of 1.56% (UI, 1.13%-2.06%). This meta-analysis found that an estimated 2.56% of people 40 years or older have glaucoma, slightly more than estimated by previous studies. Black individuals are disproportionately affected. Prevalence estimates at the state and county level can help guide public health planning.

Identifiants

pubmed: 39418040
pii: 2824476
doi: 10.1001/jamaophthalmol.2024.3884
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Joshua R Ehrlich (JR)

Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.
Institute for Social Research, University of Michigan, Ann Arbor.
Division of Diabetes Translation, Vision Health Initiative, Centers for Disease Control and Prevention, Atlanta, Georgia.

Zeb Burke-Conte (Z)

Institute for Health Metrics and Evaluation, University of Washington, Seattle.

John S Wittenborn (JS)

NORC @ the University of Chicago, Chicago, Illinois.

Jinan Saaddine (J)

Division of Diabetes Translation, Vision Health Initiative, Centers for Disease Control and Prevention, Atlanta, Georgia.

John D Omura (JD)

Division of Diabetes Translation, Vision Health Initiative, Centers for Disease Control and Prevention, Atlanta, Georgia.

David S Friedman (DS)

Glaucoma Center of Excellence, Massachusetts Eye and Ear, Harvard University, Boston.

Abraham D Flaxman (AD)

Institute for Health Metrics and Evaluation, University of Washington, Seattle.

David B Rein (DB)

NORC @ the University of Chicago, Chicago, Illinois.

Classifications MeSH